CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 193 filers reported holding CARDLYTICS INC in Q2 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,432,992 | +370.1% | 86,848 | +80.0% | 0.00% | – |
| Q2 2023 | $304,852 | +93.4% | 48,236 | +3.9% | 0.00% | – |
| Q1 2023 | $157,603 | -49.7% | 46,422 | -14.4% | 0.00% | – |
| Q4 2022 | $313,322 | +4.4% | 54,208 | +302.2% | 0.00% | – |
| Q2 2022 | $300,000 | -93.6% | 13,478 | -84.2% | 0.00% | -100.0% |
| Q1 2022 | $4,681,000 | -39.5% | 85,138 | -27.3% | 0.00% | -66.7% |
| Q4 2021 | $7,739,000 | +43.3% | 117,094 | +82.0% | 0.00% | +50.0% |
| Q3 2021 | $5,402,000 | -17.1% | 64,354 | +25.3% | 0.00% | -33.3% |
| Q2 2021 | $6,517,000 | +45.9% | 51,347 | +26.1% | 0.00% | +50.0% |
| Q1 2021 | $4,466,000 | -47.9% | 40,707 | -32.2% | 0.00% | -50.0% |
| Q4 2020 | $8,571,000 | +116.1% | 60,030 | +6.8% | 0.00% | +100.0% |
| Q3 2020 | $3,967,000 | -6.1% | 56,205 | -6.9% | 0.00% | -33.3% |
| Q2 2020 | $4,225,000 | +351.9% | 60,372 | +125.5% | 0.00% | – |
| Q1 2020 | $935,000 | +145.4% | 26,775 | +135.3% | 0.00% | -100.0% |
| Q3 2019 | $381,000 | – | 11,379 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners VIII LLC | 1,133,141 | $29,439,000 | 58.62% |
| Polaris Venture Management Co. V, L.L.C. | 2,277,342 | $59,165,000 | 46.48% |
| CAS Investment Partners, LLC | 2,162,020 | $56,169,000 | 14.39% |
| Cannell Capital | 626,975 | $16,289,000 | 4.62% |
| Antipodean Advisors LLC | 142,358 | $3,698,000 | 4.50% |
| Shannon River Fund Management LLC | 344,230 | $8,943,000 | 1.42% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 19,048 | $495,000 | 1.40% |
| Tygh Capital Management, Inc. | 176,237 | $4,579,000 | 0.78% |
| Penn Capital Management Company, LLC | 263,499 | $6,846,000 | 0.68% |
| EAM Global Investors LLC | 56,866 | $1,477,000 | 0.63% |